Improvement of Peptide-Based Tumor Immunotherapy Using pH-Sensitive Fusogenic Polymer-Modified Liposomes

Artificially synthesized helper/killer-hybrid epitope long peptide (H/K-HELP): Preparation and immunological analysis of vaccine efficacy

(2015) Kazutaka Masuko et al.   IMMUNOLOGY LETTERS

Cationic micelle delivery of Trp2 peptide for efficient lymphatic draining and enhanced cytotoxic T-lymphocyte responses

(2015) Qin Zeng et al.   JOURNAL OF CONTROLLED RELEASE

Mutant MHC class II epitopes drive therapeutic immune responses to cancer

(2015) Sebastian Kreiter et al.   NATURE

Neoantigens in cancer immunotherapy

(2015) T. N. Schumacher et al.   SCIENCE

Potentiation of pH-sensitive polymer-modified liposomes with cationic lipid inclusion as antigen delivery carriers for cancer immunotherapy

(2014) Yuta Yoshizaki et al.   BIOMATERIALS

A liposome-based antigen delivery system using pH-sensitive fusogenic polymers for cancer immunotherapy

(2013) Eiji Yuba et al.   BIOMATERIALS

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

(2013) Paul F Robbins et al.   NATURE MEDICINE

Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion

(2013) Yared Hailemichael et al.   NATURE MEDICINE

Remarkable tumor lysis in a hepatocellular carcinoma patient immediately following glypican-3-derived peptide vaccination

(2013) Yu Sawada et al.   Human Vaccines & Immunotherapeutics

The pH-Sensitive Fusogenic 3-Methyl-Glutarylated Hyperbranched Poly(Glycidol)-Conjugated Liposome Induces Antigen-Specific Cellular and Humoral Immunity

(2012) Takehisa Hebishima et al.   Clinical and Vaccine Immunology

Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

(2012) Y. Sawada et al.   CLINICAL CANCER RESEARCH

PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses

(2012) Wenxue Ma et al.   International Journal of Nanomedicine

Identification of an HLA-DPB1*0501 Restricted Melan-A/MART-1 Epitope Recognized by CD4+ T Lymphocytes

(2011) Zhaoting Meng et al.   JOURNAL OF IMMUNOTHERAPY

Carboxylated hyperbranched poly(glycidol)s for preparation of pH-sensitive liposomes

(2010) Eiji Yuba et al.   JOURNAL OF CONTROLLED RELEASE

Screening of Human Tumor Antigens for CD4+ T Cell Epitopes by Combination of HLA-Transgenic Mice, Recombinant Adenovirus and Antigen Peptide Libraries

(2010) Wolfram Osen et al.   PLoS One

pH-Sensitive fusogenic polymer-modified liposomes as a carrier of antigenic proteins for activation of cellular immunity

(2009) Eiji Yuba et al.   BIOMATERIALS

Adoptive cell therapy for the treatment of patients with metastatic melanoma

(2009) Steven A Rosenberg et al.   CURRENT OPINION IN IMMUNOLOGY

Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme

(2008) Shuichi Izumoto et al.   JOURNAL OF NEUROSURGERY